American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

✍ Scribed by Saag, Kenneth G. ;Teng, Gim Gee ;Patkar, Nivedita M. ;Anuntiyo, Jeremy ;Finney, Catherine ;Curtis, Jeffrey R. ;Paulus, Harold E. ;Mudano, Amy ;Pisu, Maria ;Elkins-Melton, Mary ;Outman, Ryan ;Allison, Jeroan J. ;Almazor, Maria Suarez ;Bridges, S. Louis ;Chatham, W. Winn ;Hochberg, Marc ;Maclean, Catherine ;Mikuls, Ted ;Moreland, Larry W. ;O'dell, James ;Turkiewicz, Anthony M. ;Furst, Daniel E.

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 315 KB
• Volume: 59
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.23721

✦ Synopsis

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.